Roberta Sgariglia
Cited by
Cited by
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients
U Malapelle, C Mayo de-Las-Casas, D Rocco, M Garzon, P Pisapia, ...
British Journal of Cancer 116 (6), 802-810, 2017
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients
U Malapelle, E Vigliar, R Sgariglia, C Bellevicine, L Colarossi, D Vitale, ...
Journal of clinical pathology 68 (1), 64-68, 2015
Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
U Malapelle, P Pisapia, R Sgariglia, E Vigliar, M Biglietto, C Carlomagno, ...
Journal of clinical pathology 69 (9), 767-771, 2016
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of …
C Bellevicine, I Migliatico, R Sgariglia, M Nacchio, E Vigliar, P Pisapia, ...
Cancer cytopathology 128 (2), 107-118, 2020
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting
M Nacchio, R Sgariglia, V Gristina, P Pisapia, F Pepe, C De Luca, ...
Journal of thoracic disease 12 (7), 3836, 2020
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting
P Pisapia, F Pepe, R Smeraglio, M Russo, D Rocco, R Sgariglia, ...
Journal of Thoracic Disease 9 (Suppl 13), S1383, 2017
Tumor mutational burden on cytological samples: a pilot study
F Pepe, P Pisapia, V Gristina, D Rocco, M Micheli, P Micheli, A Iaccarino, ...
Cancer Cytopathology 129 (6), 460-467, 2021
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations
C Bellevicine, R Sgariglia, I Migliatico, E Vigliar, M D'Anna, MA Nacchio, ...
Cancer cytopathology 126 (5), 317-325, 2018
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples
F Pepe, C De Luca, R Smeraglio, P Pisapia, R Sgariglia, M Nacchio, ...
Journal of Clinical Pathology 72 (1), 38-45, 2019
Evaluation of micro satellite instability and mismatch repair status in different solid tumors: a multicenter analysis in a real world setting
U Malapelle, P Parente, F Pepe, C De Luca, P Pisapia, R Sgariglia, ...
Cells 10 (8), 1878, 2021
Next generation sequencing in cytopathology: focus on non-small cell lung cancer
P Pisapia, F Pepe, A Iaccarino, R Sgariglia, M Nacchio, F Conticelli, ...
Frontiers in medicine 8, 633923, 2021
Next generation sequencing in cytology
P Pisapia, F Pepe, R Sgariglia, M Nacchio, G Russo, F Conticelli, ...
Cytopathology 32 (5), 588-595, 2021
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients
NA Cacciola, C Calabrese, U Malapelle, G Pellino, A De Stefano, R Sepe, ...
Molecular Carcinogenesis 55 (5), 793-807, 2016
Young investigator challenge: can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next‐generation sequencing of thyroid FNA samples?
C Bellevicine, R Sgariglia, U Malapelle, E Vigliar, M Nacchio, G Ciancia, ...
Cancer Cytopathology 124 (11), 776-784, 2016
BRAF: a two-faced Janus
P Pisapia, F Pepe, A Iaccarino, R Sgariglia, M Nacchio, G Russo, ...
Cells 9 (12), 2549, 2020
RNA-based assay for next-generation sequencing of clinically relevant gene fusions in non-small cell lung cancer
C De Luca, F Pepe, A Iaccarino, P Pisapia, L Righi, A Listi, L Greco, ...
Cancers 13 (1), 139, 2021
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study
R Sgariglia, P Pisapia, M Nacchio, C De Luca, F Pepe, M Russo, ...
Journal of Clinical Pathology 70 (9), 803-806, 2017
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic
R Palladino, I Migliatico, R Sgariglia, M Nacchio, A Iaccarino, U Malapelle, ...
Endocrine 71, 20-25, 2021
Rapid on‐site molecular evaluation in thyroid cytopathology: a same‐day cytological and molecular diagnosis
C De Luca, R Sgariglia, M Nacchio, P Pisapia, I Migliatico, E Clery, ...
Diagnostic Cytopathology 48 (4), 300-307, 2020
KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer
U Malapelle, R Sgariglia, A De Stefano, C Bellevicine, E Vigliar, ...
Journal of Clinical Pathology 68 (4), 265-269, 2015
The system can't perform the operation now. Try again later.
Articles 1–20